Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cancer Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002733
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific
Hoag Memorial Hospital Presbyterian 30
Testing effectiveness (Phase 2)Study completedNCT00078858
What this trial is testing

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more
Fred Hutchinson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT00112840
What this trial is testing

CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00121251
What this trial is testing

Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer

Who this might be right for
Recurrent Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7Stage IV Renal Cell Cancer AJCC v7
National Cancer Institute (NCI) 17
Early research (Phase 1)Ended earlyNCT00014131
What this trial is testing

Vaccine Therapy in Treating Patients With Kidney Cancer

Who this might be right for
Kidney Cancer
Lisata Therapeutics, Inc. 9
Testing effectiveness (Phase 2)Ended earlyNCT00004856
What this trial is testing

Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium

Who this might be right for
Distal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterProximal Urethral Cancer+6 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00096629
What this trial is testing

Vaccine Therapy in Treating Patients With Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT02599194
What this trial is testing

18F-FSPG PET/CT for Cancer Patients on Therapy

Who this might be right for
B-Cell NeoplasmEstrogen Receptor NegativeHER2/Neu Negative+13 more
Andrei Iagaru 7
Testing effectiveness (Phase 2)Study completedNCT01631552
What this trial is testing

Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer

Who this might be right for
Gastric AdenocarcinomaEsophageal CancerHepatocellular Carcinoma+13 more
Gilead Sciences 515
Testing effectiveness (Phase 2)Looking for participantsNCT04322318
What this trial is testing

Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Who this might be right for
Anaplastic Kidney Wilms TumorRecurrent Kidney Wilms TumorStage II Kidney Wilms Tumor+2 more
Children's Oncology Group 256
Testing effectiveness (Phase 2)UnknownNCT00717587
What this trial is testing

Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer

Who this might be right for
Kidney Cancer
Abramson Cancer Center at Penn Medicine 20
Not applicableStudy completedNCT00900276
What this trial is testing

Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants

Who this might be right for
Bladder CancerKidney CancerTransitional Cell Cancer of the Renal Pelvis and Ureter+1 more
Wake Forest University Health Sciences 5
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Testing effectiveness (Phase 2)Looking for participantsNCT06601296
What this trial is testing

Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma ( mRCC)OligoProgressive Metastatic Disease
University of Texas Southwestern Medical Center 15
Large-scale testing (Phase 3)Looking for participantsNCT05796973
What this trial is testing

Measuring Oncological Value of Exercise and Statin

Who this might be right for
Prostate CancerBreast CancerKidney Cancer+9 more
Tampere University Hospital 240
Early research (Phase 1)Study completedNCT00089362
What this trial is testing

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Looking for participantsNCT05092373
What this trial is testing

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

Who this might be right for
Advanced Breast CarcinomaAdvanced Endometrial CarcinomaAdvanced Fallopian Tube Carcinoma+71 more
M.D. Anderson Cancer Center 43
Not applicableStudy completedNCT01026337
What this trial is testing

Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Renal Cell CarcinomaStage III Renal Cell CancerStage IV Renal Cell Cancer
Abramson Cancer Center at Penn Medicine 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT04848519
What this trial is testing

Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma

Who this might be right for
Locally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+11 more
Emory University 6
Large-scale testing (Phase 3)Looking for participantsNCT06401330
What this trial is testing

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

Who this might be right for
Stage I Mixed Cell Type Kidney Wilms TumorStage II Mixed Cell Type Kidney Wilms TumorStage III Mixed Cell Type Kidney Wilms Tumor+1 more
Children's Oncology Group 1,656
Next Page